Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
检查点激酶 1 表达是 MYC 驱动的髓母细胞瘤的不良预后标志物和治疗靶点
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.10692
Eric W Prince, Ilango Balakrishnan, Monil Shah, Jean M Mulcahy Levy, Andrea M Griesinger, Irina Alimova, Peter S Harris, Diane K Birks, Andrew M Donson, Nathan Davidson, Marc Remke, Michael D Taylor, Michael H Handler, Nicholas K Foreman, Sujatha Venkataraman, Rajeev Vibhakar
